Literature DB >> 10637095

Chemokine production by rat myocytes exposed to interferon-gamma.

S M Reyes-Reyna1, K A Krolick.   

Abstract

Messenger RNA that encodes for monocyte chemotactic protein-1 (MCP-1), as well as its protein product, was observed to be constitutively expressed at low levels in a monoclonal Lewis rat skeletal muscle cell line (LE1). Immunohistochemical analyses of sections of skeletal muscle yielded similar results. Since interferon-gamma (IFN-gamma) has been reported to have a likely role in determining the severity of symptoms in the neuromuscular autoimmune disease experimental myasthenia gravis (EAMG), the hypothesis tested and proven true in these studies was that IFN-gamma would up-regulate the production of MCP-1 in LE1 cells. It was also observed that muscle-derived MCP-1 could be up-regulated in vivo in rats receiving a monoclonal anti-acetylcholine receptor antibody (mAb35), a potent inducer of symptoms of EAMG. Therefore, it is concluded that muscle may contribute to disease progression by producing factors that influence activities of the immune system. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637095     DOI: 10.1006/clim.1999.4828

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.

Authors:  Priya Londhe; Judith K Davie
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

Review 2.  Regulatory interactions between muscle and the immune system during muscle regeneration.

Authors:  James G Tidball; S Armando Villalta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-10       Impact factor: 3.619

3.  Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.

Authors:  H F Zhao; T Ito; J Gibo; K Kawabe; T Oono; T Kaku; Y Arita; Q W Zhao; M Usui; K Egashira; H Nawata
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

4.  Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production.

Authors:  Jussara Lagrota-Candido; Rita Vasconcellos; Marta Cavalcanti; Marcelo Bozza; Wilson Savino; Thereza Quirico-Santos
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

5.  CC family chemokines directly regulate myoblast responses to skeletal muscle injury.

Authors:  Linda Yahiaoui; Dusanka Gvozdic; Gawiyou Danialou; Matthias Mack; Basil J Petrof
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

6.  IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4.

Authors:  Sabrina Shandley; Sonia Martinez; Keith Krolick
Journal:  Clin Immunol       Date:  2009-04-22       Impact factor: 3.969

Review 7.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

8.  Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth.

Authors:  Bénédicte Chazaud; Corinne Sonnet; Peggy Lafuste; Guillaume Bassez; Anne-Cécile Rimaniol; Françoise Poron; François-Jerome Authier; Patrick A Dreyfus; Romain K Gherardi
Journal:  J Cell Biol       Date:  2003-12-08       Impact factor: 10.539

9.  CCR2-64I and CCR5Delta32 Polymorphisms in Korean Patients with Myasthenia Gravis.

Authors:  Hyun Sook Kim; Dae-Seong Kim; Eun Young Lee; Il-Nam Sunwoo; Young-Chul Choi
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.